Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study.
Lancet Respir Med
; 7(9): 780-790, 2019 09.
Article
in En
| MEDLINE
| ID: mdl-31416769
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrazoles
/
Pyrimidines
/
Enzyme Activators
/
Idiopathic Interstitial Pneumonias
/
Hypertension, Pulmonary
Type of study:
Clinical_trials
/
Guideline
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
Language:
En
Journal:
Lancet Respir Med
Year:
2019
Document type:
Article
Country of publication:
United kingdom